Global Embolotherapy Market- Market Overview:

The global embolotherapy market is expected to grow from USD 3.6 billion in 2022 to USD 6.7 billion by 2030, at a CAGR of 8.1% during the Projection period 2023-2030. The growth of this market is mainly driven owing to the rising cases of cardiovascular disorders.

Embolotherapy is the process of obstructing arteries with a device (such as a balloon catheter) in order to treat or stop uncontrollable bleeding. Utilizing this technique, tumours are reduced and bleeding is controlled. It is an endovascular procedure that attempts to stop bleeding by restricting aberrant blood arteries. Embolotherapy is mostly used to treat cervical uprooted pregnancy, postpartum situations, and pelvic tract haemorrhage. This treatment has shown potential in the management of iatrogenic solid organ, vascular, and non-operative organ damage, including lesions to the liver, spleen, and kidneys. Embolotherapy is used to treat enlarged uterine fibroids, devascularize tissues and organs prior to surgery, and eliminate duodenal varices. This necessitates choosing an embolization agent with the required level of vascular blockage permanence. Embolotherapy is a minimally invasive surgical technique used to stop and manage bleeding. In order to cure bleeding ulcers and blood vessel problems, embolotherapy is a surgical treatment in which the arteries are stopped by inserting coils, balloons, and other devices. The rising incidence of hepatocellular cancer and liver cancer, along with the leading manufacturers' increased attention on technological breakthroughs, will drive up demand for embolotherapy. The market value for embolotherapy will expand as a result of rising infrastructure construction costs and improved research and development capabilities to advance healthcare technology. Other factors influencing market expansion include rising personal disposable income and rising patient desire for minimally invasive procedures.

Sample Request: - Global Embolotherapy Market

Market Dynamics:

Drivers:                          

• Increasing prevalence of cancer

Over the Projection period, it is anticipated that the prevalence of several chronic diseases, such as cancer, will increase the demand for embolotherapy. For instance, according to the Centers for Disease Control (CDC), over 25,000 men and 11,000 women are diagnosed with liver cancer each year in the United States, and approximately 19,000 men and 9,000 women pass away from the condition.

Restraints:                                             

• Lack of skilled medical professionals

The market for embolotherapy would be restricted by the lack of experienced radiologists to treat patients. There is lack of skilled professionals capable of performing embolotherapy also hampers the market’s growth. The process of embolotherapy is complicated and requires a lot of  experience for performing the procedure. Thus it is very much important to have a skilled medical professionsl to perform the procedure.

Opportunities:

• Technological advancement in healthcare

Because of the rising prevalence of various types of liver cancer and the rising need for minimally invasive procedures, it is projected that the global market for embolotherapy would see increased demand. The rise in patients with hepatic cell carcinoma (HCC), varicose veins, renal cell carcinoma (RCC), and aneurysms is contributing to an increase in death rates, which is fueling the expansion of the embolotherapy industry. Additionally, it is anticipated that the market for embolotherapy would increase as a result of rising spending to upgrade healthcare infrastructure and expanding R&D for technical developments in the healthcare industry.

Challenges:

• Stringent regulatory policies

Although there are many end uses for the embolotherapy industry, there are several challenges that may limit market expansion throughout Projections. The development of the global embolotherapy market is anticipated to be constrained by strict regulatory standards for the devices used in embolotherapy systems and the expensive nature of the treatment. There are several countries which have several stringent regulatory policies for the use of devices which challenges the market’s growth.

Segmentation Analysis:

The global embolotherapy market has been segmented based on disease, embolic agents, application, and region.

By Disease

The disease segment includes oncology, peripheral vacsular diseases and others. The oncology segment led the largest share of the embolotherapy market with a market share of around 47% in 2022. The increasing number of cancer cases worldwide is the cause. According to statistics from the Centers for Disease Control and Prevention (CDC), 24,000 men and 10,000 women are diagnosed with liver cancer per year, and 18,000 men and 9,000 women die from it.

By Embolic Agents

The embolic agents segment includes liquid embolic agents, microspheres, embolic coils, detachable balloons and others. The liquid embolic agent segment led the largest share of the embolotherapy market with a market share of around 27% in 2022. It is becoming increasingly apparent that liquid embolic agents have advantages in distal infiltration that solid embolic agents cannot reach, enabling more extensive embolization than solid embolic agents. In the treatment of blood vessel embolism, liquid formulations have an established role with the widespread use of cyanoacrylate glues, precipitating polymers, oil and chemotherapeutic agents. Currently used liquid embolic products have a few shortcomings that are being addressed by the emerging market for next-generation liquid embolic products.

By Application

The end-user segment includes ambulatory surgery centres, hospitals & clinics and others. The hospitals & clinics segment led the largest share of the embolotherapy market with a market share of around 44% in 2022. A major share of the market is accounted for by the hospitals and clinics segment, which is Projection to grow at the highest CAGR over the Projection period. The segment holds a significant share due to the adoption of advanced technology in hospitals and the increase in surgeries at hospital facilities. Furthermore, minimally invasive surgical procedures are expected to drive market growth. These facilities are performing an increasing number of embolization procedures and adopting advanced embolotherapy devices to perform complex procedures, which are driving the demand for embolotherpay devices in the hospitals & clinics.

Global Embolotherapy Market- Sales Analysis.

The sale of embolotherapy expanded at a CAGR of 7.9% from 2016 to 2022.

The embolotherapy market is anticipated to increase over the course of the Projection period as a result of rising investments in the construction of healthcare infrastructure, particularly in emerging countries, and rising applications in end-use industries. When treating cancer, internal haemorrhages, aneurysms, and venous disorders, embolization, a minimally invasive endovascular technique, is used to purposefully restrict blood flow in blood vessels.

The market for embolotherapy is primarily being driven by a sedentary lifestyle that causes obesity and other cardiovascular disorders like heart attack, stroke, ischemic heart diseases (IHD), etc. Due to an increased preference for treating COVID-19 patients, embolotherapy treatments are expected to decline at the same time.

COVID 19 has a detrimental impact on the market for embolotherapy because there is a decrease in both the supply and demand for the related items. However, issues brought on by COVID-19 infections are given priority, supporting market expansion.

Thus, owing to the aforementioned factors, the global embolotherapy market is expected to grow at a CAGR of 8.1% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the embolotherapy market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the embolotherapy market and held a 39.5% share of the market revenue in 2022.

• The North American region witnessed a major share. Due to the prevalence of favourable reimbursement policies and the presence of major players, North America dominates the embolotherapy market. A high level of technologically advanced healthcare facilities will also drive the growth of the market in this area. In addition, the presence of large and global embolization product manufacturers will contribute significantly to the growth of the embolization market in this region. The global embolotherapy market is expected to be dominated by North America during the Projection period as a result of advancements in technology and recent FDA approvals of WEB systems.
• Asia Pacific is anticipated to experience significant growth during the predicted period. As a result of booming medical tourism, developing healthcare networks and increasing research and development activities, Asia-Pacific will achieve the highest growth rate during the Projection period. In countries like India and China, health care expenditures are increasing per capita as a result of the high population in these regions and the increase in cardiovascular diseases.

Global Embolotherapy Market - Country Analysis:

• Germany

Germany's embolotherapy market size was valued at USD 0.25 billion in 2022 and is expected to reach USD 0.46 billion by 2030, at a CAGR of 8.2% from 2023 to 2030.

In the coming years, the embolotherapy market in Germany is expected to grow enormously. Extensive applications in the health industry are keeping the embolotherapy market afloat. As a result of the high population in Germany, and the increasing incidence of cardiovascular diseases, the market is growing.

• China

China’s embolotherapy market size was valued at USD 1.04 billion in 2022 and is expected to reach USD 1.99 billion by 2030, at a CAGR of 8.5% from 2023 to 2030.

Increasing healthcare infrastructure expenditures as well as increased research and development skills will further drive growth in the embolotherapy market. Another factor driving the market growth of the country includes an increasing patient preference for minimally invasive procedures and an increase in personal disposable income.

• India

India's embolotherapy market size was valued at USD 0.20 billion in 2022 and is expected to reach USD 0.38 billion by 2030, at a CAGR of 8.4% from 2023 to 2030.

An array of organic developments are implemented in the Indian embolotherapy market by companies that result in dynamic market improvements. Market growth is fueled by organic growth strategies such as product launches and product development, as well as numerous inorganic strategies, including mergers and acquisitions and partnerships, boosting the market growth.

Key Industry Players Analysis:  

To increase their market position in the global embolotherapy market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

• Boston Scientific Corporation
• Balt USA LLC
• Johnson & Johnson
• Abbott
• Guerbet LLC
• Stryker
• SSEM Mthembu Medical Ltd
• Medtronic
• Cook Medical LLC
• Acandis GmbH
• Terumo Corporation

Latest Development:

• In June 2022, Despite the fact that there are many different end uses for the embolotherapy industry, there are some barriers that will probably make it difficult to predict market expansion. The rapid expansion of the global embolotherapy market is anticipated to be constrained by strict regulatory rules for the use of devices in embolotherapy systems and the expensive nature of the treatment.
• In October 2022, The first radiofrequency balloon ablation catheter, the HELIOSTARTM Balloon Ablation Catheter, has been launched in Europe, according to Biosense Webster, Inc., a division of Johnson & Johnson MedTech. When used with a compatible multi-channel RF generator, the HELIOSTARTM Balloon Ablation Catheter is indicated for cardiac ablation as well as catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	8.1%
Market Size	3.6 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Disease, By Embolic Agents, By End-User, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Boston Scientific Corporation, Balt USA LLC, Johnson & Johnson, Abbott, Guerbet LLC, Stryker, SSEM Mthembu Medical Ltd, Medtronic, Cook Medical LLC, Acandis GmbH, and Terumo Corporation.
By Disease	Oncology Peripheral Vascular Diseases Others
By Embolic Agents	Liquid Embolic Agent Microspheres Embolic Coils Detachable Balloons Others
By End-User	Ambulatory Surgery Centres Hospitals & Clinics Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Embolotherapy Market by Disease:

• Oncology
• Peripheral Vascular Diseases
• Others

Global Embolotherapy Market by Embolic Agents:

• Liquid Embolic Agent
• Microspheres
• Embolic Coils
• Detachable Balloons
• Others

Global Embolotherapy Market by End-User:

• Ambulatory Surgery Centres
• Hospitals & Clinics
• Others

Global Embolotherapy Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- The foundation of the current political system, which supports the operations of the embolotherapy  industry, is democracy. The market for embolotherapy  could become financially independent with the help of a democratic political system that encourages initiative and free commerce. By partnering with powerful media outlets, pressure organisations can have an effect on the corporate environment. By starting marketing efforts and protests, these organisations are being pressured by these groups. The embolotherapy  market must keep an eye on these pressure organisations because they have the power to affect government policy, which in turn may have an impact on the general business environment.

Economic Factors- The effectiveness of the financial market and overall economic growth, which have a strong positive link, enable capital accumulation and the creation of goods and services. The embolotherapy  firm must pick nations with incredibly efficient financial markets if it wants to quickly develop its financial and human capital. The effectiveness of the financial system can keep the market for embolotherapy  one step ahead of its rivals. The embolotherapy  market should take the rates of economic growth in the various nations into account when deciding whether to become global. Long-term growth objectives can be more easily attained in nations with high economic growth rates.

Social Factors- There are two positive demographic indicators when the embolotherapy  market's products/services are primarily targeted at young consumers: rapid population growth and an increasing share of the young population group. The embolotherapy  market should take into account the host country's perspective on immigration because a friendly attitude toward immigrants from varied cultural origins implies that diversity management methods should be utilised. Marketers of embolotherapy  must alter their marketing techniques in order to promote diversity and inclusion. A positive perspective on migration also shows how individuals from all cultural backgrounds can readily find employment in the modern coils market. Diversity in the workplace is frequently linked to increased productivity, enhanced innovation, and improved overall corporate performance.

Technological Factors- The direction of research and development in the selected field or industry reveals how forward-thinking companies are in commercialising ground-breaking discoveries. The market for embolotherapy  has to comprehend how new technological developments can help the sector and benefit consumers. Markets with disruptive technology would require a substantial investment in research and development. The embolotherapy  sector must, however, keep a long-term perspective and refrain from anticipating a speedy return on R&D investments.

Environmental Factors- In a range of nations and industries, the use of the closed-loop, circular economy concept is growing in popularity. Industries that gain from supportive institutional frameworks can enable material recycling and reuse. Similar to this, recycling is a well-liked practise everywhere in the world. The embolotherapy  market may benefit from these sustainability trends by selling more products and using them as a tool to minimise costs associated with production and environmental concerns.

Legal Factors- There are numerous federal and state legislation in place in a number of nations to safeguard consumers from potential economic exploitation. The laws governing consumer privacy have tightened in the era of digital technology. the resources market for embolotherapy  Businesses must rigorously abide by data privacy laws when conducting online transactions in order to prevent lawsuits. Market suppliers for embolotherapy  must review local laws controlling returns, discounts, credit terms, quality, deceptive advertising, and maximum price before entering new markets (particularly in the case of basic essential goods).

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Disease
     • 3.2. Market Attractiveness Analysis By Embolic Agents
     • 3.3. Market Attractiveness Analysis By End-User
     • 3.4. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Increasing prevalence of cancer
   • 3. Restraints
     • 3.1. Lack of skilled medical professionals
   • 4. Opportunities
     • 4.1. Technological advancement in healthcare
   • 5. Challenges
     • 5.1. Stringent regulatory policies

6. Global Embolotherapy Market Analysis and Projection, By Disease
   • 1. Segment Overview
   • 2. Oncology
   • 3. Peripheral Vascular Diseases
   • 4. Others
7. Global Embolotherapy Market Analysis and Projection, By Embolic Agents
   • 1. Segment Overview
   • 2. Liquid Embolic Agent
   • 3. Microspheres
   • 4. Embolic Coils
   • 5. Detachable Balloons
   • 6. Others
8. Global Embolotherapy Market Analysis and Projection, By End-User
   • 1. Segment Overview
   • 2. Ambulatory Surgery Centres
   • 3. Hospitals & Clinics
   • 4. Others
9. Global Embolotherapy Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

10. Global Embolotherapy Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Embolotherapy Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Technology Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

11. Company Profiles
    • Boston Scientific Corporation
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Balt USA LLC
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Johnson & Johnson
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Abbott
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Guerbet LLC
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Stryker
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Technology Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • SSEM Mthembu Medical Ltd
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Technology Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Medtronic
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Technology Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • Cook Medical LLC
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Technology Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Acandis GmbH
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis
    • Terumo Corporation
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
2. Global Oncology, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
3. Global Peripheral Vascular Diseases, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
4. Global Others, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
5. Global Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
6. Global Liquid Embolic Agent, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
7. Global Microspheres, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
8. Global Embolic Coils, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
9. Global Detachable Balloons, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
10. Global Others, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
11. Global Embolotherapy Market, By End-User 2023–2030 (USD Billion)
12. Global Ambulatory Surgery Centres, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
13. Global Hospitals & Clinics, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
14. Global Others, Embolotherapy Market, By Region, 2023–2030 (USD Billion)
15. Global Embolotherapy Market, By Region, 2023–2030 (USD Billion)
16. North America Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
17. North America Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
18. North America Embolotherapy Market, By End-User 2023–2030 (USD Billion)
19. USA Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
20. USA Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
21. USA Embolotherapy Market, By End-User 2023–2030 (USD Billion)
22. Canada Embolotherapy Market, By Disease 2023–2030 (USD Billion)
23. Canada Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
24. Canada Embolotherapy Market, By End-User 2023–2030 (USD Billion)
25. Mexico Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
26. Mexico Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
27. Mexico Embolotherapy Market, By End-User 2023–2030 (USD Billion)
28. Europe Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
29. Europe Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
30. Europe Embolotherapy Market, By End-User 2023–2030 (USD Billion)
31. Germany Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
32. Germany Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
33. Germany Embolotherapy Market, By End-User 2023–2030 (USD Billion)
34. France Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
35. France Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
36. France Embolotherapy Market, By End-User 2023–2030 (USD Billion)
37. UK Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
38. UK Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
39. UK Embolotherapy Market, By End-User 2023–2030 (USD Billion)
40. Italy Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
41. Italy Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
42. Italy Embolotherapy Market, By End-User 2023–2030 (USD Billion)
43. Spain Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
44. Spain Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
45. Spain Embolotherapy Market, By End-User 2023–2030 (USD Billion)
46. Asia Pacific Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
47. Asia Pacific Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
48. Asia Pacific Embolotherapy Market, By End-User 2023–2030 (USD Billion)
49. Japan Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
50. Japan Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
51. Japan Embolotherapy Market, By End-User 2023–2030 (USD Billion)
52. China Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
53. China Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
54. China Embolotherapy Market, By End-User 2023–2030 (USD Billion)
55. India Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
56. India Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
57. India Embolotherapy Market, By End-User 2023–2030 (USD Billion)
58. South America Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
59. South America Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
60. South America Embolotherapy Market, By End-User 2023–2030 (USD Billion)
61. Brazil Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
62. Brazil Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
63. Brazil Embolotherapy Market, By End-User 2023–2030 (USD Billion)
64. Middle East and Africa Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
65. Middle East and Africa Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
66. Middle East and Africa Embolotherapy Market, By End-User 2023–2030 (USD Billion)
67. UAE Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
68. UAE Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
69. UAE Embolotherapy Market, By End-User 2023–2030 (USD Billion)
70. South Africa Embolotherapy Market, By Disease, 2023–2030 (USD Billion)
71. South Africa Embolotherapy Market, By Embolic Agents, 2023–2030 (USD Billion)
72. South Africa Embolotherapy Market, By End-User 2023–2030 (USD Billion)

List of Figures 

1. Global Embolotherapy Market Segmentation
2. Embolotherapy Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Embolotherapy Market Attractiveness Analysis By Disease
9. Global Embolotherapy Market Attractiveness Analysis By Embolic Agents
10. Global Embolotherapy Market Attractiveness Analysis By End-User
11. Global Embolotherapy Market Attractiveness Analysis By Region
12. Global Embolotherapy Market: Dynamics
13. Global Embolotherapy Market Share By Disease (2023 & 2030)
14. Global Embolotherapy Market Share By Embolic Agents (2023 & 2030)
15. Global Embolotherapy Market Share By End-User (2023 & 2030)
16. Global Embolotherapy Market Share by Regions (2023 & 2030)
17. Global Embolotherapy Market Share by Company (2021)